Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies.
Danciu OC, Holdhoff M, Peterson RA, Fischer JH, Liu LC, Wang H, Venepalli NK, Chowdhery R, Nicholas MK, Russell MJ, Fan TM, Hergenrother PJ, Tarasow TM, Dudek AZ.
Danciu OC, et al. Among authors: fischer jh.
Br J Cancer. 2023 Mar;128(5):783-792. doi: 10.1038/s41416-022-02089-7. Epub 2022 Dec 5.
Br J Cancer. 2023.
PMID: 36470974
Free PMC article.
Clinical Trial.